INOVIO and Advaccine have all 640 subjects dosed for the first vaccination in a Phase 2 clinical trial in China. The primary endpoints will evaluate ...
Source link
INOVIO and Advaccine have all 640 subjects dosed for the first vaccination in a Phase 2 clinical trial in China. The primary endpoints will evaluate ...
Source link